Terns Pharmaceuticals
TERN
TERN
45 hedge funds and large institutions have $134M invested in Terns Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
7% more funds holding
Funds holding: 42 → 45 (+3)
Holders
45
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$21.8M | |
| 2 | +$19M | |
| 3 | +$12.1M | |
| 4 |
DM
Deerfield Management
New York
|
+$11M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.17M |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$3.07M | |
| 3 | -$2.17M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.24M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$995K |